Frequencies of mutagenic translesion DNA synthesis over cisplatin-guanine intra-strand crosslinks in lacZ plasmids propagated in human cells

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 770, Issue , 2014, Pages 23-28

  Fujikawa, Yoshihiro ^a,d   Kawanishi, Masanobu ^a   Kuraoka, Isao ^b   Yagi, Takashi ^a,c  

^a Osaka Prefecture University   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c Dongguk University   (South Korea)

^d OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cisplatin; Intra strand crosslink; Mutation; Translesion DNA synthesis

Indexed keywords

BETA GALACTOSIDASE; CISPLATIN; DNA; GUANINE; MUTAGENIC AGENT;

ARTICLE; BACTERIAL CELL; CROSS LINKING; DNA REPLICATION; DNA SYNTHESIS; EXCISION REPAIR; GENE MUTATION; HUMAN; HUMAN CELL; MUTAGENESIS; PLASMID; PRIORITY JOURNAL; XERODERMA PIGMENTOSUM; DNA DAMAGE; DNA REPAIR; DRUG EFFECTS; GENETICS; LACTOSE OPERON; TOXICITY;

CISPLATIN; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; GUANINE; HUMANS; LAC OPERON; MUTAGENESIS; MUTAGENS; PLASMIDS; XERODERMA PIGMENTOSUM;

EID: 84902210103     PISSN: 13835718     EISSN: 18793592     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2014.05.006     Document Type: Article

References (30)

1. Friedberg E.C., Walker G.C., Siede W., Wood R.D., Schultz R.A., Ellenberger T. DNA Repair and Mutagenesis 2006, ASM Press, Washington, DC.
2. Rabik C.A., Dolan M.E. Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat. Rev. 2007, 33:9-23.
3. Eastman A. Characterization of the adducts produced in DNA by cis-diamminedichloroplatinum(II) and cis-dichloro(ethylenediamine)platinum(II). Biochemistry 1983, 22:3927-3933.
4. Fichtinger-Schepman A.M., van der Veer J.L., den Hartog J.H., Lohman P.H., Reedijk J. Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation. Biochemistry 1985, 24:707-713.
5. Eastman A. Reevaluation of interaction of cis-dichloro(ethylenediamine)platinum(II) with DNA. Biochemistry 1986, 25:3912-3915.
6. Furuta T., Ueda T., Aune G., Sarasin A., Kraemer K.H., Pommier Y. Transcription-coupled nucleotide excision repair as a determinant of cisplatin sensitivity of human cells. Cancer Res. 2002, 62:4899-4902.
7. Köberle B., Masters J.R., Hartley J.A., Wood R.D. Defective repair of cisplatin-induced DNA damage caused by reduced XPA protein in testicular germ cell tumours. Curr. Biol. 1999, 9:273-276.
8. Welsh C., Day R., McGurk C., Masters J.R., Wood R.D., Köberle B. Reduced levels of XPA, ERCC1 and XPF DNA repair proteins in testis tumor cell lines. Int. J. Cancer 2004, 110:352-361.
9. Dabholkar M., Vionnet J., Bostick-Bruton F., Yu J.J., Reed E. Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy. J. Clin. Invest. 1994, 94:703-708.
10. Li Q., Yu J.J., Mu C., Yunmbam M.K., Slavsky D., Cross C.L., Bostick-Bruton F., Reed E. Association between the level of ERCC-1 expression and the repair of cisplatin-induced DNA damage in human ovarian cancer cells. Anticancer Res. 2000, 20:645-652.
11. Dabholkar M., Thornton K., Vionnet J., Bostick-Bruton F., Yu J.J., Reed E. Increased mRNA levels of xeroderma pigmentosum complementation group B (XPB) and Cockayne's syndrome complementation group B (CSB) without increased mRNA levels of multidrug-resistance gene (MDR1) or metallothionein-II (MT-II) in platinum-resistant human ovarian cancer tissues. Biochem. Pharmacol. 2000, 60:1611-1619.
12. Waters L.S., Minesinger B.K., Wiltrout M.E., D'Souza S., Woodruff R.V., Walker G.C. Eukaryotic translesion polymerases and their roles and regulation in DNA damage tolerance. Microbiol. Mol. Biol. Rev. 2009, 73:134-154.
13. Foti J.J., Walker G.C. SnapShot: DNA polymerases II mammals. Cell 2010, 141:370.
14. Shachar S., Ziv O., Avkin S., Adar S., Wittschieben J., Reissner T., Chaney S., Friedberg E.C., Wang Z., Carell T., Geacintov N., Livneh Z. Two-polymerase mechanisms dictate error-free and error-prone translesion DNA synthesis in mammals. EMBO J. 2009, 28:383-393.
15. Schneider S., Reissner T., Ziv O., Livneh Z., Carell T. Translesion synthesis of 1,3-GTG cisplatin DNA lesions. Chembiochem 2010, 11:1521-1524.
16. Chijiwa S., Masutani C., Hanaoka F., Iwai S., Kuraoka I. Polymerization by DNA polymerase eta is blocked by cis-diamminedichloroplatinum(II) 1,3-d(GpTpG) cross-link: implications for cytotoxic effects in nucleotide excision repair-negative tumor cells. Carcinogenesis 2010, 31:388-393.
17. Sawai T., Kawanishi M., Takamura-Enya T., Yagi T. Establishment of a method for analyzing translesion DNA synthesis across a single bulky adduct in human cells. Genes Environ. 2009, 31:24-30.
18. Punchihewa C., Inoue A., Hishiki A., Fujikawa Y., Connelly M., Evison B., Shao Y., Heath R., Kuraoka I., Rodrigues P., Hashimoto H., Kawanishi M., Sato M., Yagi T., Fujii N. Identification of small molecule proliferating cell nuclear antigen (PCNA) inhibitor that disrupts interactions with PIP-box proteins and inhibits DNA replication. J. Biol. Chem. 2012, 287:14289-14300.
19. Kawanishi M., Fujikawa Y., Ishii H., Nishida H., Higashigaki Y., Kanno T., Matsuda T., Takamura-Enya T., Yagi T. Adduct formation and repair, and translesion DNA synthesis across the adducts in human cells exposed to 3-nitrobenzanthrone. Mutat. Res. 2013, 753:93-100.
20. Takebe H., Nii S., Ishii MI M.I., Utsumi H. Comparative studies of host-cell reactivation colony forming ability and excision repair after UV irradiation of xeroderma pigmentosum, normal human and some other mammalian cells. Mutat. Res. 1974, 25:383-390.
21. Shivji M.K., Moggs J.G., Kuraoka I., Wood R.D. Assaying for the dual incisions of nucleotide excision repair using DNA with a lesion at a specific site. Methods Mol. Biol. 2006, 314:435-456.
22. Baik M.H., Friesner R.A., Lippard S.J. Theoretical study on the stability of N-glycosyl bonds: why does N7-platination not promote depurination?. Am. Chem. Soc. 2001, 124:4495-4503.
23. Reißner T., Schneider S., Schorr S., Carell T. Crystal structure of a cisplatin-(1,3-GTG) cross-link within DNA polymerase eta. Angew. Chem. Int. Ed. Engl. 2010, 49:3077-3080.
24. van Garderen C.J., van Houte L.P. The solution structure of a DNA duplex containing the cis-Pt(NH3)2[d(-GTG-)-N7(G),N7(G)] adduct, as determined with high-field NMR and molecular mechanics/dynamics. Eur. J. Biochem. 1994, 225:1169-1179.
25. Teuben J.M., Bauer C., Wang A.H., Reedijk J. Solution structure of a DNA duplex containing a cis-diammineplatinum(II) 1,3-d(GTG) intrastrand cross-link, a major adduct in cells treated with the anticancer drug carboplatin. Biochemistry 1999, 38:12305-12312.
26. Louro H., Silva M.J., Boavida M.G. Mutagenic activity of cisplatin in the lacZ plasmid-based transgenic mouse model. Environ. Mol. Mutagen. 2002, 40:283-291.
27. Fichtinger-Schepman A.M., van Oosterom A.T., Lohman P.H., Berends F. cis-Diamminedichloroplatinum(II)-induced DNA adducts in peripheral leukocytes from seven cancer patients: quantitative immunochemical detection of the adduct induction and removal after a single dose of cis-diamminedichloroplatinum(II). Cancer Res. 1987, 47:3000-3004.
28. Zamble D.B., Mu D., Reardon J.T., Sancar A., Lippard S.J. Repair of cisplatin-DNA adducts by the mammalian excision nuclease. Biochemistry 1996, 35:10004-10013.
29. Brown J.A., Newmister S.A., Fiala K.A., Suo Z. Mechanism of double-base lesion bypass catalyzed by a Y-family DNA polymerase. Nucleic Acids Res. 2008, 36:3867-3878.
30. Vaidyanathan V.G., Cho B.P. Sequence effects on translesion synthesis of an aminofluorene-DNA adduct: conformational, thermodynamic, and primer extension kinetic studies. Biochemistry 2012, 51:1983-1995.